Estonia: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
BirthMonthsYears
234-561226-712131415-1618256065≥ 66
Coronavirus disease (COVID-19)1
COVID-19
tuberculosis
BCG3
rotavirus infection
ROTA
ROTA
ROTA4
diphtheria
D
D
D
D
D
d
d5
tetanus
TT
TT
TT
TT
TT
TT
TT5
pertussis
acP
acP
acP
acP
acP
acp
poliomyelitis
IPV
IPV
IPV
IPV
IPV
Haemophilus influenzae type b infection
Hib
Hib
Hib
Hib
hepatitis B
HepB6
HepB
HepB
HepB
HepB
pneumococcal disease
PCV13/PCV15 + PPSV23 or PCV207
PCV13 or PCV15 or PCV20 or PPSV23
measles
MEAS
MEAS
mumps
MUMPS
MUMPS
rubella
RUBE
RUBE
human papillomavirus infection
HPV9 (F/M)8
HPV9 (F/M)8
influenza2
IIV49
IIV4
herpes zoster
ZOS

Version:


Footnotes:

  1. see 2023/24 recommendations here: https://vaktsineeri.ee/et/covid-19
  2. Influenza immunization is recommended for: 1) recipients of continued general care services and special care services provided outside the home, recipients of community living services within the meaning of the Social Welfare Act; 2) for persons aged 60 and older; 3) for children aged 6 months to 7 years; 4) for pregnant women; 5) for minors over 7 years of age who have an increased risk of becoming seriously ill due to their health condition (cardiovascular diseases, oncological diseases, immunodeficiency, diabetes and obstructive lung disease).
  3. Administration in the 1-5 days after birth
  4. 3rd dose only for pentavalent rotavirus vaccines
  5. Subsequent Td booster every 10 years
  6. Within 12 hours after birth, recommended for babies born from HepB positive mother
  7. Risk groups list is published here: https://terviseamet.ee/sites/default/files/documents/2024-07/pneumo-_ja_meningokokk-nakkuse_korge_riskiga_riskiruhmad.pdf
  8. As of February 2023, boys included in the programme - one dose scheme. free catch-up for 15-18-year-olds
  9. Vaccination is free for the following groups: residents of welfare institutions, people aged 60 years and older, children aged six months to seven years old, pregnant women, children and adolescents 7–17 years old who have an increased risk of becoming seriously ill due to their health condition (heart and blood vessel diseases, oncological diseases, immunodeficiency, diabetes and obstructive lung disease).


More information available at:
https://ta.vaktsineeri.ee/en


--------------------------------------------------------------------------------


ADDITIONAL INFORMATION

1. After bone marrow transplantation, persons with the corresponding indication can also be immunized free of charge with vaccines, included to the national immunisation schedule. Other vaccines are chargeable.

2. When there is a risk of epidemic spread of infectious diseases, individuals of all age groups can be immunized free of charge with vaccines, included to the national immunisation schedule in the amount of up to 500 vaccine doses. Other vaccines are chargeable.


--------------------------------------------------------------------------------

MAJOR HISTORICAL CHANGES

2003: HepB vaccination for newborns was included in the national immunization schedule

2005 Sept. : Hib vaccine was included in the national immunization schedule

2008: Pertussis vaccine: change over from wP to aP in the public sector. Poliomyelitis vaccine: change over from OPV to IPV.

2012 Jan.: dTap included into the national immunisation schedule

2014 July : Rota vaccine is included in the national immunization schedule

2018 Jan
HPV vaccination introduced
Hexavalent vaccination introduced



Measles, mumps and rubella:
1964: Measles vaccination introduced to children aged 1-8 years of age.
1973: Age of measles vaccination lowered to 10 months.
1980: Age of measles vaccination shifted to 15-18 months and second measles vaccine introduced at 6 years of age.
1981: Mumps vaccine introduced to children aged 15-18 months.
1993: Rubella vaccine introduced to children aged 6 years.
1994: MMR replaces measles-only vaccination. Age of MMR vaccination regimen changed and recommended at 12 months (MMR1) and at 12 years (MMR2).
1997: Recommended age of MMR2 changed from 12 years to 13 years.

--------------------------------------------------------------------------------

Date of last update: 30 Jan. 2024

--------------------------------------------------------------------------------